Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950129-01-001871
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
7
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 TEXAS BIOTECHNOLOGY CORPORATION - 12/31/2000 h83395e10-k.txt 10-K 262063
2 LICENSE & RESEARCH & DEVELOPMENT AGMT. - 7/21/00 h83395ex10-74.txt EX-10.74 92768
3 5TH AMENDMENT TO CONSULTING AGREEMENT h83395ex10-75.txt EX-10.75 3836
4 EXERCIS OF RENEWAL OPTION IN LEASE AGREEMENT h83395ex10-76.txt EX-10.76 1511
5 AMENDMENT TO LEASE AGREEMENT - 1/1/2001 h83395ex10-77.txt EX-10.77 7077
6 SUBSIDIARIES OF THE REGISTRANT h83395ex22.txt EX-22 477
7 INDEPENDENT AUDITORS' CONSENT h83395ex23-1.txt EX-23.1 1189
  Complete submission text file 0000950129-01-001871.txt   371175
Mailing Address
Business Address 7000 FANNIN 20TH FLR HOUSTON TX 77030 7137968822
TEXAS BIOTECHNOLOGY CORP /DE/ (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20117 | Film No.: 1592123
SIC: 2836 Biological Products, (No Diagnostic Substances)